MNGIE patients needed to map disease course and speed up future treatments
NCT ID NCT07627217
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study gathers medical information from people with MNGIE, a rare genetic disease that affects the nerves and digestive system. Researchers want to learn how the disease progresses and find better ways to measure it. Up to 50 patients worldwide can join, and no new treatments or procedures are given. The results will help design future clinical trials for potential therapies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Clinical Neurosciences
RECRUITINGCambridge, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.